Trial intelligence / Profile preview

Diabetes Prevention Trial of Type 1 Diabetes

NCT00004984Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Feb 1994
Primary completion
Jun 2003
Modality
Recombinant Proteins and Enzymes
Countries
2
01

Overview

Phase 3, randomised trial of human insulin in type 1 diabetes mellitus (T1D) (4 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Rate of Type 1 Diabetes Per Year. Started Feb 1994; status: completed.

02

Drugs

human insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00004984.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004984.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call